Skip to content

Senate Council Meeting: “When there is a temporary reduction in Pathology Laboratory capacity, how can pathology demand be managed or reduced with the least possible risk of clinical harm?”

On the 26th November 2020 the Clinical Senate deliberated the questions: “When there is a temporary reduction in Pathology Laboratory capacity, how can pathology demand be managed or reduced with the least possible risk of clinical harm? Presentations Bruce Daniel Pathology Laboratory Capacity in the South West – Clinical senate 26.11.20 Bruce, Pathology Service Manager…

Read More

Senate Council Meeting: Test and Trace Strategy

On the 24th September 2020 the Clinical Senate deliberated the question: “What should be the future Test and Trace Strategy for COVID 19 in the SW and how can we influence it?” Presentations Maggie Rae, Public Health England (National Initiatives and System Perspective) Debbie Stark, Public Health England (Regional Position & Data) Bruce Laurence, DPH,…

Read More

Senate Council Pathway Proposal: Delivery of immunosuppressant chemotherapy

At the request of the South West and Peninsula Cancer Alliances, the South West Clinical Senate coordinated a discussion between clinicians from the cancer alliances and the senate, supported by expert input from Infection Prevention Control Leads and colleagues from Public Health England to agree a pathway for the delivery of immunosuppressant chemotherapy. Read the…

Read More

Senate Council Review: Operating framework for urgent and planned services in hospital settings during COVID-19

At the request of South West Regional Medical and Nursing Directors from NHS England and Improvement on 18th May, the South West Clinical Senate reviewed the recently published national guidance for hospitals to maintain provision for patients with COVID-19, whilst resuming other clinical services. The review meeting took place on 21st May 2020 and the…

Read More